What’s new

• Commercial production for Hydra vacuum bottles is pushed from March to late June.
• The 20 MW solar plant commissioning is deferred to Q1 FY27.
• Medium-term EBITDA margin target is downgraded to 20%.

Why it matters

The company's operational delays and margin downgrades signal a difficult path to profitability. Rising gas costs and global supply chain disruptions have clearly eroded earnings quality.

What we’re watching

• Whether the Hydra facility meets the new end-of-June production target.
• Progress on the 20 MW solar plant commissioning.
• Signs of margin recovery in Q1 FY27.

The full read

Borosil faces a slower start to the fiscal year as it navigates delays across its manufacturing and infrastructure projects. The new Hydra vacuum bottle facility, initially slated for a March launch, is now pushed until the end of the June quarter.

It is falling behind.

Simultaneously, the company deferred the commissioning of its 20 MW solar plant to Q1 FY27. These operational setbacks arrive alongside a clear reset in profitability expectations. Management shifted its medium-term EBITDA margin guidance to 20%, retreating from its previous, more optimistic 'low-20s' forecast. This adjustment follows a rough FY26, where revenue grew 8% to ₹1,195.9 crore, yet EBITDA margins slipped 160 basis points to 15.1% under the weight of higher gas costs and ongoing West Asian supply chain disruptions. The company’s inability to meet its prior project timelines combined with a lower margin floor makes the current quarter the real test for management’s credibility.

Primary source: BSE · NSE

What’s new

• Shreevar Kheruka re-designated as Managing Director, no longer CEO.
• Rituraj Sharma, a 20+ year insider, appointed as new CEO.
• No prior indication from company filings of this change.

Why it matters

Unexpected CEO changes at small-caps often precede strategic shifts. The separation of MD/CEO roles may improve governance but also signals Kheruka is stepping back from day-to-day operations. The open question is whether strategy or execution will shift post-transition.

What we’re watching

• Will there be a strategic pivot under new CEO Rituraj Sharma?
• Any significant stock move or change in coverage frequency.
• Further board or management changes in the coming months.

The full read

Borosil announced a surprise leadership change. Shreevar Kheruka, who held the combined MD/CEO role, is now only MD, effectively ceding day-to-day control to Rituraj Sharma, a two-decade insider. The move was not telegraphed in recent filings. For a small-cap with a ₹2,731 crore market cap, such a change is material. Internal promotion suggests continuity, but the separation of roles could presage a governance upgrade or a shift in strategy. The open question is whether this is a planned transition or a response to performance pressures.

Primary source: BSE · NSE